檢索結果 - Angela D’Angelo

Refine Results
  1. 1
    A Clinical Trial about a Food Supplement Containing α-Lipoic Acid on Oxidative Stress Markers in Type 2 Diabetic Patients

    A Clinical Trial about a Food Supplement Containing α-Lipoic Acid on Oxidative Stress Markers in Type 2 Diabetic Patients 由 Giuseppe Derosa, Angela D’Angelo, Davide Romano, Pamela Maffioli

    出版 2016
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  2. 2
    Effects of metformin extended release compared to immediate release formula on glycemic control and glycemic variability in patients with type 2 diabetes

    Effects of metformin extended release compared to immediate release formula on glycemic control and glycemic variability in patients with type 2 diabetes 由 Giuseppe Derosa, Angela D’Angelo, Davide Romano, Pamela Maffioli

    出版 2017
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  3. 3
    Effects of a Combination of Berberis aristata, Silybum marianum and Monacolin on Lipid Profile in Subjects at Low Cardiovascular Risk; A Double-Blind, Randomized, Placebo-Controlled Trial

    Effects of a Combination of Berberis aristata, Silybum marianum and Monacolin on Lipid Profile in Subjects at Low Cardiovascular Risk; A Double-Blind, Randomized, Placebo-Controlle... 由 Giuseppe, Derosa, Angela, D’Angelo, Davide, Romano, Pamela, Maffioli

    出版 2017
    獲取全文 獲取全文 獲取全文
    Text
    加到收藏夾
    Saved in:
  4. 4
    Evaluation of the Effects of Mesoglycan on Some Markers of Endothelial Damage and Walking Distance in Diabetic Patients with Peripheral Arterial Disease

    Evaluation of the Effects of Mesoglycan on Some Markers of Endothelial Damage and Walking Distance in Diabetic Patients with Peripheral Arterial Disease 由 Giuseppe, Derosa, Angela, D’Angelo, Romano, Davide, Pamela, Maffioli

    出版 2017
    獲取全文 獲取全文 獲取全文
    Text
    加到收藏夾
    Saved in:
  5. 5
    A role for quercetin in coronavirus disease 2019 (COVID‐19)

    A role for quercetin in coronavirus disease 2019 (COVID‐19) 由 Giuseppe Derosa, Pamela Maffioli, Angela D’Angelo, Francesco Di Pierro

    出版 2020
    獲取全文
    Revisão
    加到收藏夾
    Saved in:
  6. 6
    Sepsis and AKI in ICU Patients: The Role of Plasma Biomarkers

    Sepsis and AKI in ICU Patients: The Role of Plasma Biomarkers 由 Paolo Lentini, Massimo de Cal, Anna Clementi, Angela D’Angelo, Claudio Ronco

    出版 2012
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  7. 7
    The Use of Nigella sativa in Cardiometabolic Diseases

    The Use of Nigella sativa in Cardiometabolic Diseases 由 Giuseppe Derosa, Angela D’Angelo, Pamela Maffioli, Laura Cucinella, Rossella E. Nappi

    出版 2024
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  8. 8
    Effects of 1-year orlistat treatment compared to placebo on insulin resistance parameters in patients with type 2 diabetes

    Effects of 1-year orlistat treatment compared to placebo on insulin resistance parameters in patients with type 2 diabetes 由 Giuseppe Derosa, Arrigo F.G. Cicero, Angela D’Angelo, Elena Fogari, Pamela Maffioli

    出版 2011
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  9. 9
    Medullary sponge kidney (Lenarduzzi–Cacchi–Ricci disease): A Padua Medical School discovery in the 1930s

    Medullary sponge kidney (Lenarduzzi–Cacchi–Ricci disease): A Padua Medical School discovery in the 1930s 由 Giovanni Gambaro, G.P. Feltrin, Antonio Lupo, Luciana Bonfante, Angela D’Angelo, Augusto Antonello

    出版 2006
    獲取全文
    Revisão
    加到收藏夾
    Saved in:
  10. 10
    Psoriasis and Diabetes, a Dangerous Association: Evaluation of Insulin Resistance, Lipid Abnormalities, and Cardiovascular Risk Biomarkers

    Psoriasis and Diabetes, a Dangerous Association: Evaluation of Insulin Resistance, Lipid Abnormalities, and Cardiovascular Risk Biomarkers 由 Valeria Brazzelli, Pamela Maffioli, Vittorio Bolcato, Christian Ciolfi, Angela D’Angelo, Carmine Tinelli, Giuseppe Derosa

    出版 2021
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  11. 11
    Plasma Levels of Soluble Receptor for Advanced Glycation End Products and Coronary Artery Disease in Nondiabetic Men

    Plasma Levels of Soluble Receptor for Advanced Glycation End Products and Coronary Artery Disease in Nondiabetic Men 由 Colomba Falcone, Enzo Emanuele, Angela D’Angelo, Maria Paola Buzzi, Chiara Belvito, Mariaclara Cuccia, Diego Geroldi

    出版 2005
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  12. 12
    Heparanase and Syndecan-1 Interplay Orchestrates Fibroblast Growth Factor-2-induced Epithelial-Mesenchymal Transition in Renal Tubular Cells

    Heparanase and Syndecan-1 Interplay Orchestrates Fibroblast Growth Factor-2-induced Epithelial-Mesenchymal Transition in Renal Tubular Cells 由 Valentina Masola, Giovanni Gambaro, Elena Tibaldi, Anna Maria Brunati, Alessandra Gastaldello, Angela D’Angelo, Maurizio Onisto, Antonio Lupo

    出版 2011
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  13. 13
    Acute effects of moderate dietary protein restriction in patients with idiopathic hypercalciuria and calcium nephrolithiasis

    Acute effects of moderate dietary protein restriction in patients with idiopathic hypercalciuria and calcium nephrolithiasis 由 Sandro Giannini, M. Nobile, Leonardo Sartori, Luca Dalle Carbonare, Matteo Ciuffreda, Paolo Corrò, Angela D'Angelo, Lorenzo A. Calò, Gaetano Crepaldi

    出版 1999
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  14. 14
    Galectin-3 Plasma Levels and Coronary Artery Disease: A New Possible Biomarker of Acute Coronary Syndrome

    Galectin-3 Plasma Levels and Coronary Artery Disease: A New Possible Biomarker of Acute Coronary Syndrome 由 Colomba Falcone, Simona Lucibello, Iolanda Mazzucchelli, Sara Bozzinì, Angela D’Angelo, Sandra Schirinzi, Rossana Totaro, Rossana Falcone, M. Bondesan, Gabriele Pelissero

    出版 2011
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  15. 15
    Effects of dietary protein and phosphorus restriction on the progression of early renal failure

    Effects of dietary protein and phosphorus restriction on the progression of early renal failure 由 Giuseppe Maschio, Lamberto Oldrizzi, Nicola Tessitore, Angela D’Angelo, E. Valvo, Antonio Lupo, C. Loschiavo, Antonia Fabris, Linda Gammaro, Carlo Rugiu, Giovanni Panzetta

    出版 1982
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  16. 16
    Alendronate Prevents Further Bone Loss in Renal Transplant Recipients

    Alendronate Prevents Further Bone Loss in Renal Transplant Recipients 由 Sandro Giannini, Angela D’Angelo, Gianni Carraro, M. Nobile, Paolo Rigotti, Luciana Bonfante, Francesco Marchini, Martina Zaninotto, Luca Dalle Carbonare, Leonardo Sartori, G Crepaldi

    出版 2001
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  17. 17
    Metabolic effects of telmisartan and irbesartan in type 2 diabetic patients with metabolic syndrome treated with rosiglitazone

    Metabolic effects of telmisartan and irbesartan in type 2 diabetic patients with metabolic syndrome treated with rosiglitazone 由 Giuseppe Derosa, Elena Fogari, Angela D’Angelo, Arrigo F.G. Cicero, Sibilla Salvadeo, P. D. Ragonesi, Ilaria Ferrari, Alessia Gravina, Raffaella Fassi, Roberto Fogari

    出版 2007
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  18. 18
    Probiotic Therapy With VSL#3® in Patients With NAFLD: A Randomized Clinical Trial

    Probiotic Therapy With VSL#3® in Patients With NAFLD: A Randomized Clinical Trial 由 Giuseppe Derosa, Luigina Guasti, Angela D’Angelo, Chiara Martinotti, Maria Chiara Valentino, Sergio Di Matteo, Giacomo Matteo Bruno, Andrea Maria Maresca, Giovanni Gaudio, Pamela Maffioli

    出版 2022
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  19. 19
    Telmisartan and Irbesartan Therapy in Type 2 Diabetic Patients Treated with Rosiglitazone: Effects on Insulin-Resistance, Leptin and Tumor Necrosis Factor-.ALPHA.

    Telmisartan and Irbesartan Therapy in Type 2 Diabetic Patients Treated with Rosiglitazone: Effects on Insulin-Resistance, Leptin and Tumor Necrosis Factor-.ALPHA. 由 Giuseppe Derosa, Arrigo F.G. Cicero, Angela D’Angelo, Pietro D. Ragonesi, Leonardina Ciccarelli, Mario N. Piccinni, F. Pricolo, Sibilla Salvadeo, Ilaria Ferrari, Alessia Gravina, Roberto Fogari

    出版 2006
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  20. 20
    Metformin–pioglitazone and metformin–rosiglitazone effects on non-conventional cardiovascular risk factors plasma level in type 2 diabetic patients with metabolic syndrome

    Metformin–pioglitazone and metformin–rosiglitazone effects on non-conventional cardiovascular risk factors plasma level in type 2 diabetic patients with metabolic syndrome 由 Giuseppe Derosa, Angela D’Angelo, P. D. Ragonesi, Leonardina Ciccarelli, Mario N. Piccinni, F. Pricolo, Sibilla Salvadeo, Lorenza Montagna, Alessia Gravina, Ilaria Ferrari, S. Paniga, Arrigo F.G. Cicero

    出版 2006
    獲取全文
    Artigo
    加到收藏夾
    Saved in:

檢索工具: